News & Events

As a young company, Amferia is growing fast and establishing ground both in Sweden and Internationally. To keep updated on our progress and activities, do check on the below posts and don’t hesitate to contact us if you would like to know more.

News & Events

Agneta Edberg appointed Chairperson

July 28, 2022

Read our Press Release in English here

Amferia AB is happy to announce the appointment of Agneta Edberg as the new Chairperson of the company’s Board of Directors. Agneta has extensive background from the life-science industry bringing knowledge and experience for the continued growth of Amferia.

Amferia presenting at the European Wound Management Association (EWMA) congress 2022 in Paris

May 17, 2022

Read our Press Release in English here

We welcome all attendees to our stand located in room 252A at the congress venue, Palais des Congrès de Paris, to know more about Amferia and clinical evidence for human and animal wound care as well as for an introduction to our soon-to-be launched wound dressings for animal wound care.

We also invite all attendees to our scientific talk at the symposium for Veterinary Wound Healing Association (VWHA) on 24th May at 08:45 hrs room 252A.

For more information and booking meetings at EWMA, please contact
Saba Atefyekta, Sales Director and Co-founder
Phone: +46 70 844 94 96

Amferia Granted US Patent for its Antimicrobial Material Platform

May 9, 2022

Read our Press Release in English here


Amferia AB announced today that it has been granted the foundational patent by the United States Patent and Trademark Office (USPTO) for its innovative antimicrobial material based on an amphiphilic antimicrobial hydrogel. The company is now in its final stages of product development for wound care applications and aims to launch the first product within animal health during 2022.

Amferia’s technology recognized as one of the top 100 research based innovations of 2021 by the Royal Swedish Academy of Engineering Sciences.

May 26, 2021

Amferia announces partnership with Triolab to Launch innovative Wound Care Products for veterinary applications

 May 6, 2021


Amferia  and Triolab AB – Sweden’s largest distributor of premium medical & diagnostic devices have entered into a strategic partnership to jointly launch Amferia’s antimicrobial wound care products for the Swedish veterinary market.

Read full press release here:

EN: Read press release in english

SE: Read press release in swedish

Amferia is proud to be selected as “One-to-Watch” company of 2020 by the Nature Research and Merck KGaA, as part of the Nature Research Spin-Off Awards!

17 April, 2021

This is a wonderful recognition of the top 44 university spin-off’s from around the world! A big thanks to Chalmers University of Technology & Chalmers Ventures for the continued support for Amferia and our growth!

More to read here:

Amferia’s  Founders publish  important results in high impact biomaterials journal, ACS Biomaterials Science & Engineering.

March 15, 2021


Revealing the exciting and impressive pre-clinical results of Amferia’s core-wound care technology – the amphiphilic and antimicrobial mesoporous hydrogels!

Want to know more? Check out this interesting article published in the prestigious journal ACS Biomaterials Science and Engineering, by our colleagues Saba, Edvin and Martin in joint collaboration with researchers from Chalmers, Sahlgrenska, North Eastern University, Boston and Uppsala University


 Saba had the pleasure of speaking at the Women in Tech 2020

06 March 2020

Watch the entire talk on our homepage

Amferia’s CTO, Saba Atefyekta is a PhD in Materials Science .

07 February 2020

Yesterday, Saba successfully defended her thesis (and work of true importance), ‘Antibacterial Surfaces for Biomedical Applications’ with a highly engaging discussion with her opponent and pioneer in the field, Professor Henk Busscher from the Netherlands.

Congratulations Doctor Atefyekta!

Amferia is happy to announce its raising of SEK 6.2 million in investment .

22 January 2020 

Almi Invest, Chalmers Ventures, along with the British investor Corithinan Properties Ltd. and Let’s Deal Founder Alexander Hars have invested a total of SEK 6.2 million in Amferia, for commercialising our wound care product that actively combats infections and kills antibiotic-resistant bacteria. Read press release here:Investment Press release_Amferia

Amferia’s  Founders publish results in high impact nanotechnology journal, ACS Nano.

20 December 2019

Introducing a new class of elastomer materials! Want to know more? Check out this interesting article published in the prestigious journal ACS Nano, by our Founders Anand, Martin and colleagues from Chalmers University of Technology.

Amferia at 2nd Soirée Franco-Suédoise, Paris

December 2, 2019

We had the honour to be part of the 2nd Soirée Franco-Suédoise at Palais d’Iéna organized by Chambre de Commerce Suédoise en France – CCSF and represent Amferia as one of the innovative med-tech start-up from Sweden. Big thanks to Katarina Lööf and the Chambre de Commerce Suédoise en France – CCSF for inviting Amferia and introducing us to new possibilities in France. hashtag#innovation  hashtag#antibioticresistance


Photo copyright Swedish Chamber of Commerce in France and photographer Kristofer Sandberg.

Invited to Pitch for L’Oréal Paris as part of the European Innovation Council

November 26, 2019

Amferia had the honor to present our work at L’Oréal, Paris as part of the European Innovation Council’s corporate days. A lot of inspiring discussions and 1-1’s on synergies within the cosmetic research. Big thanks to the EU Commission, EUeic and L’Oréal for organising and hosting us. Also a big thank you to Chalmers Ventures for offering valuable support for Amferia to attend the event.

Amferia establishes R&D operations at AstraZeneca’s BioVentureHub

October 28, 2019


Amferia is very excited to move into the BioVentureHub, given the strong benefits of operating in a flourishing environment with state-of-the-art infrastructure dedicated to medtech and life science companies. We are also eager to be around so many experts within life science ranging from established to early-stage companies researching in biopharmaceuticals, medical devices and diagnostics. Amferia looks forward to be part of, learn and grow in this supportive and exciting community. Read press release here: Amferia AZ Press Release

Amferia Participates in the Annual Veterinary Hygiene Conference 2019

October 24, 2019

Our CEO, Anand Kumar Rajasekharan and Product Engineer, Edvin Blomstrand had the pleasure to recently attend the annual Veterinary Hygiene Conference in Knivsta, Stockholm. One of the primary questions of this conference was about handling antibiotic resistant infections in animal wound care – a fast growing problem in Sweden and Globally. Many interesting & enlightening discussions with expert veterinary clinicians taught us a lot about the needs and challenges in animal wound care and how Amferia might expand its innovative solutions to help veterinary healthcare. Thanks for a great conference VVHF.

Amferia wins the Start-up of the Year award at Venture Cup Sweden 2019!

The Jury's Motivation for Amferia!

“With its disruptive solution, the team has the opportunity to shake several industries as they tackle one of humanity’s greatest global threats. By addressing a world problem, millions of lives will be saved. By changing the behavior of the consumer, there is also the potential to reform the market.”

“Med sin disruptiva lösning har teamet en möjlighet att skaka om flera branscher när de tacklar ett av mänsklighetens största globala hot. Genom att angripa ett världsproblem kommer miljontals liv att kunna räddas. Genom att förändra beteende hos konsumenten finns det även potential till att reformera marknaden.”

Amferia receives the prestigious EU SME Instrument (Phase 1) Grant from the European Union

Aug 1, 2019

Amferia recieves the highly competitive and coveted EU SME Instrument Phase 1 grant of 50k Euros along with the valuable business coaching to take forward our technology into the market. 

Amferia at Brilliant Minds 2019, Stockholm

June 15, 2019

Amferia was honored to pitch as one of the ‘Next Brilliant in Tech‘ at Brilliant Minds 2019 held at Stockholm between 13-15 June. With esteemed guests like President Barack Obama, Secretary John Kerry, Greta Thunberg, the conference was a enlighetening and inspiring event with much hope for the future.

Our CEO, Anand  conferred a PhD  in Materials Science  

May 18, 2019. 

Chalmers Doktorspromotion 2019

Anand was also invited to speak at the ceremony about how a research study opened pathways to entrepreneurship and to the birth of Amferia. Thank you Chalmers for the wonderful oppurtunity! 

Amferia is ‘Student Superstart’!

 – Venture Cup Väst 2019 

May 21, 2019

Once again Amferiashows up among the winners! We are so proud to be one of the winners of region west Venture Cup 2019. Such a fantastic event filled with inspiration and excitement.

The Recent UN Report on Antibiotic Resistance

May 3, 2019

The United Nations appointed Interagency Coordination Group on Antimicrobial Resistance (IACG) has presented its report on Recommendations to Combat Antimicrobial Resistance (AMR). It is clear from the report that AMR is a global and complex threat that needs to be addressed with extreme urgency and with care. Consistent, coordinated and conscious actions are demanded, especially from the World Goverments, Academia, Public, Healthcare-Industry and  Agriculture. A world where bacterial infections cannot be fought efficiently is a world of perils.

Here is an excerpt from the IACG report.

“The challenges of antimicrobial resistance are complex and multifaceted, but they are not insurmountable. Implementation of the recommendations in this report will help to save millions of lives, preserve antimicrobials for generations to come and secure the future from drug-resistant diseases.

But there is no time to wait.” 

-IACG Report, April 29, 2019

Do take a minute and read the summary of this important report Englishpdf, 653kb

Amferia presenting at the European Wound Management Conference (EWMA) 2019

In June, Anand will give a presentation about Amferia’s technology at the EWMA conference this year. Please let us know if you would like to meet and discuss more at the congress. Anand’s talk is on 5th June within the Antimicrobial session.

Amferia on Låt Oss Prata – Juan Navas, Swedbank                 May 3, 2019

Our CEO, Anand had a chat with Juan Navas from Swedbank on Swedbank’s official podcast, Låt Oss Prata (Let’s Talk). Anand and Juan discuss Amferia’s recent experience on winning the Swedbank Rivstart Entrepreneur competition.

Amferia featured in Göteborgs-Posten

February 8, 2019

Read on to know more

Amferia wins the Swedbank Rivstart 2018

February 7, 2019

Amferia is proud to become the winners of the annual entrepreneur competition hosted by Swedbank, Rivstart. From over 1825 applications, Amferia finished on top!

Amferia wins the Venture Day 2018, hosted by Chalmers Ventures

November 28, 2018

Amferia is proud to be named winners of the annual Pitch competition hosted by Chalmers Ventures.